By now, many of us are familiar with the story of Elizabeth Holmes and her late biotech startup, Theranos. And while it’s easy to write the whole story off as the work of a troubled person, the truth is: Theranos, at its inception, had a groundbreaking idea, one that many well-respected people invested millions into.
Theranos’s blood-testing method — which promised to detect a range of illnesses with just a prick — was designed to be as small, compact, and lightning-fast as possible because, the story went, Holmes and her mother were both terrified by needles. The technology — if it had been realized — would have revolutionized the healthcare industry. So it's no surprise that this idea seduced many high-profile investors.
Ahead, we've compiled a list of investors who put a considerable chunk of change towards the now-defunct Theranos. While the Theranos debacle is juicy from a bystander standpoint, it’s clearly been financially devastating for those who bought into the hype.